- Home
- TCBS vs TIL Comparison
TCBS vs TIL Comparison
Compare TCBS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBS | TIL |
|---|---|---|
| Founded | 1934 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 54.8M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TCBS | TIL |
|---|---|---|
| Price | $17.78 | $7.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $125.00 |
| AVG Volume (30 Days) | 4.9K | ★ 18.4K |
| Earning Date | 04-24-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 327.27 | 6.06 |
| EPS | ★ 0.31 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $57.35 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.10 | $5.67 |
| 52 Week High | $20.00 | $33.83 |
Technical Indicators
Market Signals| Indicator | TCBS | TIL |
|---|---|---|
| Relative Strength Index (RSI) | 64.56 | 24.94 |
| Support Level | $15.86 | $6.85 |
| Resistance Level | $18.05 | $8.30 |
| Average True Range (ATR) | 0.29 | 0.19 |
| MACD | 0.09 | -0.06 |
| Stochastic Oscillator | 91.97 | 0.00 |
Price Performance
Historical ComparisonAbout TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.